Research Paper Volume 15, Issue 17 pp 8833—8850
Comprehensive analysis of ICD-related lncRNAs in predicting risk stratification, clinical prognosis and immune response for breast cancer
Figure 3. Independent prognostic evaluation of ICDRLs prognostic features. (A, B) Univariate and multivariate COX analysis calculating HR and p-values for different clinical-pathological variables and ICDRLs prognostic features. (C) Development of a nomogram based on different clinical-pathological variables and ICDRLs prognostic features. (D–K) Clinical survival outcome evaluation of risk subgroups based on ICDRLs prognostic features in different clinical-pathological features.